1/59
Comprehensive vocabulary flashcards covering leukocyte extravasation, systemic versus local inflammation, immune suppression mechanisms, evolutionary immunology, and trained innate immunity.
Immune Regulation
The physiological process of controlling the magnitude and duration of an immune response so that it is effective at clearing perturbations while minimizing damage to host tissues.
Immune Activation
The induction of an immune response initiated by pattern and damage recognition that drives effector modules to eliminate infections or other perturbations.
Effector Responses
Immune mechanisms that clear perturbations like infection, carrying the trade-offs of damaging host tissues and risking accidental immunity against self or harmless antigens.
Immune Suppression
The active dampening of immunity mediated by suppressive cytokines and clearance of immune activators, preventing host tissue damage at the risk of impairing timely pathogen clearance.
Rolling Adhesion
The first step of leukocyte extravasation where leukocytes roll along activated endothelial cells via low-affinity interactions between Sialyl-LewisX glycans and selectins.
Sialyl-LewisX Glycan
A carbohydrate ligand displayed on the surface of rolling leukocytes that interacts reversibly with endothelial E-selectin and P-selectin.
Selectins (E-selectin and P-selectin)
Cell-adhesion molecules upregulated on the luminal surface of activated vascular endothelial cells that bind Sialyl-LewisX glycans to initiate rolling adhesion.
Tight Binding
The firm arrest and flattening of rolling leukocytes onto the endothelium, mediated by conformational activation of leukocyte integrins binding to endothelial ICAM-1.
LFA-1 (Lymphocyte Function-Associated Antigen 1)
A leukocyte integrin that undergoes high-affinity conformational activation to bind ICAM-1 on endothelial cells during tight binding.
ICAM-1 (Intercellular Adhesion Molecule 1)
An endothelial adhesion protein that serves as the membrane ligand for leukocyte LFA-1 to achieve firm leukocyte arrest.
Diapedesis
The process by which an arrested leukocyte squeezes through adjacent endothelial cells to cross the vascular basement membrane into inflamed tissue.
CXCL8
An inflammatory chemokine presented on endothelial proteoglycans and within the tissue that recruits neutrophils along a chemotactic gradient.
CXCR1 and CXCR2
G-protein coupled chemokine receptors expressed on neutrophils that bind CXCL8 to guide directional migration into inflamed tissues.
Localized Immunity
An immune response confined to a specific tissue area that supports host protection and limits pathogen replication through localized recruitment and controlled systemic signaling.
Fever Induction
A controlled systemic response wherein cytokines released into circulation signal the hypothalamus and fat cells to elevate core body temperature, restricting pathogen replication.
Systemic Immunity
A hazardous state occurring when pathogens enter the blood (bacteremia or viremia), triggering an uncontrolled positive feedback loop of widespread cytokine production and immune cell activation.
Cytokine Storm
A massive, dysregulated hyperproduction of cytokines that overwhelms cellular clearance capabilities, resulting in circulatory collapse, multi-organ failure, and death.
Local TNF-alpha Response
The secretion of TNF-β in infected tissue by resident macrophages, leading to plasma protein leakage, leukocyte extravasation, local vessel occlusion, and drainage to local lymph nodes.
Systemic TNF-alpha Response
The large-scale secretion of TNF-β into the bloodstream by activated macrophages in the liver and spleen, causing systemic edema, hypoproteinemia, neutropenia, and vascular collapse.
Disseminated Intravascular Coagulation (DIC)
Widespread microvascular clotting triggered by circulating TNF-β during systemic inflammation, leading to extensive tissue wasting and multiple organ failure.
Immunopathology
Host tissue damage resulting from excessive, unrestrained, or chronic inflammation, exemplified by inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Autoimmunity
A failure of immune regulation in which an adaptive immune response is inappropriately mounted against host self-proteins, as in Type 1 diabetes.
Allergy
An inappropriate adaptive immune response directed against harmless environmental antigens, such as food allergens.
Efferocytosis
The phagocytic engulfment and clearance of apoptotic cells and cellular debris, reducing pro-inflammatory signals and stimulating the release of suppressive cytokines.
Suppressive Cytokines
Anti-inflammatory molecules, primarily produced by macrophages and dendritic cells following efferocytosis or prolonged stimulation, that serve as brakes to resolve inflammation.
Interleukin-10 (IL-10)
A suppressive cytokine that binds its receptor on innate immune cells to inhibit ongoing effector functions and resolve inflammatory responses.
Transforming Growth Factor-Beta (TGF-beta)
A suppressive cytokine (TGF-β) that acts through cell surface receptors to restrain innate effector mechanisms and support tissue homeostasis.
Innate Immunity Specificity
A non-specific mode of recognition directed against conserved microbe-specific molecules such as LPS, glycans, and microbial DNA.
Adaptive Immunity Specificity
An antigen-specific mode of immune recognition capable of discriminating diverse proteins, peptides, and carbohydrates.
Innate Immunity Action Time
A rapid activation profile that initiates quickly following initial exposure to infectious microorganisms.
Adaptive Immunity Action Time
A slow activation profile that develops 2 to 6 days later than the innate immune response.
Innate Immunity Persistence
A short-duration response that rapidly diminishes after the clearance of activating microbes.
Adaptive Immunity Persistence
A long-lasting immune state that provides sustained functional protection over extended periods.
Classical View of Innate Memory
The historical doctrine stating that innate immune cells possess no memory, mounting a secondary response identical in magnitude and time course to the primary response.
Adaptive Immunity Memory
The specialized capability of adaptive immune cells to mount an accelerated, significantly higher-magnitude response upon second exposure to an antigen.
Innate Immune Receptors
Pattern recognition receptors that are germ-line encoded and do not undergo somatic gene rearrangement.
Adaptive Immune Receptors
Antigen receptors encoded in segmented genes whose high diversity relies on somatic gene rearrangement.
Infection Course Lacking Innate Immunity
A trajectory characterized by uncontrolled, rapid microbial proliferation that leads to host death before adaptive defenses can mobilize.
Infection Course Lacking Adaptive Immunity
A trajectory where innate immunity initially limits microbial load, but the host fails to clear the infection, resulting in a plateaued or persistent microbial burden.

Star Ascidian
A marine invertebrate that represents the closest invertebrate relative to humans, possessing innate immunity but completely lacking an adaptive immune system.

Lamprey
The most distant vertebrate relative to humans, which utilizes an alternative adaptive immune system based on Variable Lymphocyte Receptors (VLRs).

Elephant Shark
The most distant jawed vertebrate relative to humans, possessing a classical immunoglobulin (Ig)-based adaptive immune system.
Variable Lymphocyte Receptors (VLRs)
Leucine-rich repeat-based non-immunoglobulin receptors that mediate adaptive immunity in jawless fishes like the lamprey.
Immunoglobulin (Ig)-Based Immunity
The conventional adaptive immune system found in jawed vertebrates (from cartilaginous fishes to mammals), representing only approximately 1% of living animal diversity.
Non-Vertebrate Immune Memory
The ability of invertebrates and plants (representing roughly 99% of living diversity) to resist secondary re-infection despite lacking an adaptive immune system.
Trained Innate Immunity
A prolonged, non-specific memory state in innate immune cells (such as monocytes and macrophages) characterized by enhanced responsiveness upon secondary stimulation.
Heterologous Infection
A secondary infection caused by a pathogen distinct from the priming organism, against which trained innate immune cells still provide heightened protection.
Trained Monocyte Phenotype
An activated state of human monocytes induced after BCG vaccination, marked by increased TLR4 expression and elevated production of pro-inflammatory cytokines upon restimulation.
Mycobacterium bovis Isolation (1908)
The initial isolation of Mycobacterium bovis, which later served as the precursor for generating the attenuated Bacillus Calmette-Guérin (BCG) vaccine.
Calmette and Guérin (1921)
The researchers who derived low-virulence Mycobacterium bovis (named BCG), which was administered to humans for the first time in 1921.
Lloyd et al. (1959)
A landmark study demonstrating that the BCG vaccine produces non-specific antitumor effects in animal models.
Pathogen-Induced Non-Specific Protection (1964)
The experimental observation that host infection with certain bacterial pathogens confers non-specific cross-protection against unrelated infections.
Bistoni et al. (1988)
A study demonstrating that the non-specific protective effects mediated by BCG vaccination are T and B cell independent.
Garly et al. (2003)
An epidemiological study demonstrating that BCG vaccination reduces overall infant and child mortality through non-specific protective mechanisms.
Netea et al. (2011)
The research group that formally coined the term 'trained immunity' to describe non-specific innate immune memory.
Epigenetic Reprogramming of Innate Cells (2012)
The discovery by Kleinnijenhuis and colleagues demonstrating that BCG induces trained immunity in human monocytes through stable epigenetic modifications.
Aerobic Glycolysis in Trained Immunity (2014)
The metabolic shift toward aerobic glycolysis shown to be a critical metabolic adaptation for establishing and maintaining trained innate immunity.
HSC Reprogramming (2018)
The finding that BCG vaccination induces in vivo reprogramming of bone marrow hematopoietic stem cells, sustainably generating trained monocyte and macrophage lineages.
Histone Marks in Trained Immunity
Epigenetic modifications where resting trained cells retain H3K4me1 at latent enhancers, enabling rapid acquisition of H3K4me3 and H3K27Ac and high gene transcription upon restimulation.
Adenovirus-Induced Respiratory Trained Immunity
An experimental model where intranasal adenovirus exposure primes alveolar macrophages for at least 16 weeks, increasing neutrophil chemokine secretion and host survival against secondary bacterial challenge.